Shopping Cart
- Remove All
Your shopping cart is currently empty
AGN 210676 is a selective agonist of prostaglandin EP2(EC50 : 5 nM).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,820 | 8-10 weeks | |
| 50 mg | $2,380 | 8-10 weeks | |
| 100 mg | $3,100 | 8-10 weeks |
| Description | AGN 210676 is a selective agonist of prostaglandin EP2(EC50 : 5 nM). |
| Targets&IC50 | DP receptor (human):7749 nM (EC50), EP2 receptor:5 nM (EC50), EP3A receptor (human):153 nM (EC50) |
| In vitro | AGN 210676 is useful for the treatment of glaucoma, ocular hypertension, inflammatory bowel disease, and the other diseases or conditions disclosed herein[1]. AGN 210676 (Compound 23) also is a less potent agonist for recombinant human prostaglandin receptors hEP3A and hDP with EC50s of 153 nM and 7749 nM, respectively. |
| Synonyms | Simenepag |
| Molecular Weight | 431.55 |
| Formula | C23H29NO5S |
| Cas No. | 910562-15-1 |
| Relative Density. | 1.253 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.